3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Weight Loss
1
Pancreatic Neoplasms
1
Hematologic Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Cachexia
1
Adenocarcinoma
1
Interventions
Gemcitabine
27
Fluorouracil
25
Oxaliplatin
21
Cisplatin
19
Leucovorin
17
Bevacizumab
15
130-nm albumin-bound paclitaxel
13
Docetaxel
12
Capecitabine
12
Albumin-Bound Paclitaxel
12
Paclitaxel
11
Irinotecan
10
Carboplatin
9
pembrolizumab
7
Radiotherapy
6
Pemetrexed
6
Nivolumab
6
Erlotinib Hydrochloride
6
Cyclophosphamide
6
Trastuzumab
5
Ramucirumab
5
Ipilimumab
4
Everolimus
4
Crizotinib
4
Cetuximab
4
vandetanib
3
trastuzumab deruxtecan
3
sargramostim
3
folfirinox
3
Sorafenib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Adenocarcinoma
×
bermekimab
×
Clear all
NCT03207724
2020-12-30
OnFX
Cedars-Sinai Medical Center
Phase 1
Completed
16 enrolled